The drug that acts by inhibition of PCSK-9 is Evolocumab. PCSK-9 inhibitors are a class of drugs that work by increasing the availability of LDL receptors on liver cells, thus lowering LDL cholesterol levels in the blood. Evolocumab is a monoclonal antibody that inhibits PCSK-9, thereby reducing LDL cholesterol levels.